Literature DB >> 13468227

A study of cetiprin as a urologic drug.

G JONSSON, B ZEDERFELDT.   

Abstract

Entities:  

Keywords:  PARASYMPATHOMIMETICS/therapeutic use; URINARY TRACT/diseases

Mesh：

Substances：

Year:  1957        PMID： 13468227     DOI： 10.1159/000277270

Source DB:  PubMed          Journal:  Urol Int        ISSN： 0042-1138            Impact factor:   2.089


× No keyword cloud information.
  5 in total

Review 1.  The lower urinary tract.

Authors:  J M Robinson
Journal:  Br J Clin Pharmacol       Date:  1982-06       Impact factor: 4.335

2.  Clinical trial of emepronium bromide in nocturnal frequency of old age.

Authors:  J C Brocklehurst; J B Dillane; J Fry; P Armitage
Journal:  Br Med J       Date:  1969-04-26

3.  Non-cholinergic transmission by post-ganglionic motor neurones in the mammalian bladder.

Authors:  N Ambache; M A Zar
Journal:  J Physiol       Date:  1970-10       Impact factor: 5.182

4.  Clinical observations with Cetiprin (emepronium bromide).

Authors:  A Hamvas; I Romics; F Balogh
Journal:  Int Urol Nephrol       Date:  1981       Impact factor: 2.370

5.  The effect of parenteral emepronium bromide (Cetiprin) on postoperative vesical tenesms after transurethral resection of the prostate. A randomized, placebo-controlled study.

Authors:  L Jørgensen; H Willumsen; J R Lautorp; B Paaschburg; B Kromann; J T Andersen
Journal:  Int Urol Nephrol       Date:  1987       Impact factor: 2.370
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.